Known for its immunity brand Redoxon, energy brand Berroca, and fertility and infant nutrition brand Elevit, Bayer said its nutritionals sales were down 8.4 per cent on a reported basis to €1.43 bn (US$1.56bn).
Nutritionals is the second largest category for Bayer Consumer Health business, contributing 23 per cent of the division’s €6.03 bn (US$6.57bn) sales in FY23. Dermatology was the largest portfolio with 24 per cent sales share.
Bayer Consumer Health’s portfolio also consists of digestive health, allergy, pain, cough and cold, and cardiovascular health products.
The company said…
